Premium
Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors
Author(s) -
Miller C. H.,
Boylan B.,
Shapiro A. D.,
Lentz S. R.,
Wicklund B. M.
Publication year - 2017
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.13795
Subject(s) - limit (mathematics) , detection limit , disease , disease control , medicine , risk factor , virology , mathematics , statistics , mathematical analysis
Essentials Immunologic methods detect factor VIII (FVIII) antibodies in some inhibitor‐negative specimens. Specimens were tested by modified Nijmegen‐Bethesda assay (NBA) and fluorescence immunoassay. The NBA with preanalytical heat inactivation detects FVIII inhibitors down to 0.2 NBU. IgG 4 frequency validates the established threshold for positivity of ≥ 0.5 NBU for this NBA.Summary Background The Bethesda assay for measurement of factor VIII inhibitors called for quantification of positive inhibitors by using dilutions producing 25–75% residual activity ( RA ), corresponding to 0.4–2.0 Bethesda units, with the use of ‘more sensitive methods’ for samples with RA closer to 100% being recommended. The Nijmegen modification (Nijmegen‐Bethesda assay [ NBA ]) changed the reagents used but not these calculations. Some specimens negative by the NBA have been shown to have FVIII antibodies detectable with sensitive immunologic methods. Objective To examine the performance at very low inhibitor titers of the Centers for Disease Control and Prevention ( CDC )‐modified NBA ( CDC ‐ NBA ), which includes preanalytic heat inactivation to liberate bound anti‐ FVIII antibodies. Methods Specimens with known inhibitors were tested with the CDC ‐ NBA . IgG 4 anti‐ FVIII antibodies were measured by fluorescence immunoassay ( FLI ). Results Diluted inhibitors showed linearity below 0.4 Nijmegen‐Bethesda units ( NBU ). With four statistical methods, the limit of detection of the CDC ‐ NBA was determined to be 0.2 NBU . IgG 4 anti‐ FVIII antibodies, which correlate most strongly with functional inhibitors, were present at rates above the background rate of healthy controls in specimens with titers ≥ 0.2 NBU and showed an increase in frequency from 14.3% at 0.4 NBU to 67% at the established threshold for positivity of 0.5 NBU . Conclusions The CDC ‐ NBA can detect inhibitors down to 0.2 NBU . The FLI , which is more sensitive, demonstrates anti‐ FVIII IgG 4 in some patients with negative (< 0.5) NBU . The sharp increase in IgG 4 frequency between 0.4 and 0.5 NBU validates the established threshold for positivity of ≥ 0.5 NBU for the CDC ‐ NBA , supporting the need for method‐specific thresholds.